Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide activates GLP-1 receptors in the brain to reduce hunger and slow stomach emptying—but these effects typically require sustained dosing to become fully established. A one-month trial may produce initial appetite suppression, yet most clinical evidence supports longer treatment windows to see significant, stable weight reduction and metabolic benefits.
What Happens During Your First Month of Semaglutide
The first four weeks of semaglutide therapy focus on dose escalation and tolerance. Most patients start at a low injection dose and increase gradually to minimize nausea and digestive side effects. During this ramp-up phase, you may notice reduced hunger signals and slightly smaller meal portions, but your body is still adjusting to the medication's presence.
Week one to two typically brings mild appetite suppression as the drug reaches steady-state levels in your bloodstream. Week three to four often intensifies these sensations as your GLP-1 receptor pathway becomes more sensitized. Even so, one month alone rarely produces the sustained weight loss seen in patients who continue treatment for three, six, or twelve months.
Short-Term GLP-1 Use and Weight Loss Reality
Clinical trials of semaglutide show that meaningful weight reduction—defined as loss of five to ten percent of body weight—typically emerges between weeks eight and twelve of consistent therapy. A single month may result in one to three pounds of loss, largely from reduced calorie intake and initial water weight. Without continuation, most patients regain this weight within weeks as hunger hormones return to baseline.
The STEP trials, which studied once-weekly semaglutide injections, found that patients needed at least three to six months at therapeutic doses to experience durable metabolic changes. One-month trials lack this duration, making it difficult to distinguish true medication effects from placebo response or temporary calorie restriction alone.
Why Commitment Length Matters for GLP-1 Success
GLP-1 medications work best when the body has time to adapt to sustained receptor activation and dietary habit changes to take root. A minimum three-month commitment allows your dose to reach therapeutic levels, your digestive system to stabilize, and your brain's satiety signals to reset. Stopping after one month prevents your body from fully experiencing these adaptations.
Patients who discontinue semaglutide short-term often experience rapid hunger rebound, as their GLP-1 receptor sensitivity returns to pre-treatment levels. This rebound effect can make a one-month experiment feel disappointing, when in fact the medication simply did not have sufficient time to establish lasting appetite control patterns.
PlexusDx Semaglutide Injections and Flexible Treatment Plans
PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at $149 per month, with no membership fees or insurance required. This pricing remains flat regardless of your eventual dose level, meaning your price won't increase as your body's needs change. Patients can start, pause, or adjust their plan monthly based on real-world results and tolerance.
The Precision Peptide Genetic Test—available as an add-on after your first month—maps how your unique genetic variants in GLP1R, GIPR, FTO, and MC4R genes influence your response to semaglutide. This insight helps PlexusDx tailor your long-term strategy, suggesting whether extended treatment or dose optimization may serve your goals better than short-term use alone.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I lose weight in just one month on semaglutide?
Yes, initial weight loss of one to three pounds is common in month one due to reduced appetite and calorie intake. However, this short timeframe does not allow your body to fully establish the metabolic changes that semaglutide delivers at weeks eight to twelve.
What does the clinical evidence say about short-term GLP-1 therapy?
The STEP trials and real-world studies show that semaglutide's full appetite-suppressing and weight-loss effects emerge after eight to twelve weeks of consistent use at therapeutic doses. One-month use is too brief to separate medication benefits from placebo response, calorie restriction alone, or initial water-weight loss.
How much does a month of PlexusDx semaglutide cost?
PlexusDx compounded semaglutide injections start at $149 per month, with no membership fee or insurance required. This price holds steady as your dose increases—your dose may need to go up, but your price won't. HSA and FSA accounts are eligible for payment.
Will my appetite and weight return if I stop after one month?
Most patients experience rapid rebound hunger within one to four weeks after stopping semaglutide, since GLP-1 receptor sensitivity returns to baseline. Weight regain typically follows unless sustained dietary and exercise habits are already established. This is why longer treatment windows improve long-term outcomes.
How can PlexusDx's genetic test help me decide on treatment length?
The Precision Peptide Genetic Test examines your GLP1R, GIPR, FTO, and MC4R variants across 14 pathways and 49 peptides to predict your personalized response to semaglutide.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do Diabetics Lose Weight on Mounjaro? Exploring the Impact of Tirzepatide
Do You Lose More Weight on Higher Doses of Ozempic?